MCID: THY009
MIFTS: 39

Thyroid Lymphoma malady

Categories: Blood diseases, Cancer diseases, Rare diseases, Immune diseases, Endocrine diseases

Aliases & Classifications for Thyroid Lymphoma

About this section

Aliases & Descriptions for Thyroid Lymphoma:

Name: Thyroid Lymphoma 10 12 51 65

Classifications:



External Ids:

Disease Ontology10 DOID:10011
NCIt42 C5265
Orphanet51 97285
UMLS65 C1336753

Summaries for Thyroid Lymphoma

About this section
Wikipedia:68 Thyroid lymphoma is a rare malignant tumor constituting 1% to 2% of all thyroid malignancies and less... more...

MalaCards based summary: Thyroid Lymphoma is related to vulvar benign neoplasm and soft tissue sarcoma childhood. An important gene associated with Thyroid Lymphoma is TP53 (Tumor Protein P53), and among its related pathways are Proteolysis Putative SUMO-1 pathway and African trypanosomiasis. Affiliated tissues include thyroid, b cells and bone, and related mouse phenotypes are pigmentation and limbs/digits/tail.

Related Diseases for Thyroid Lymphoma

About this section

Diseases related to Thyroid Lymphoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 166)
idRelated DiseaseScoreTop Affiliating Genes
1vulvar benign neoplasm10.2FAS, TP53
2soft tissue sarcoma childhood10.2TNF, TP53
3proliferative fasciitis10.2TNF, TP53
4pyosalpinx10.2TNF, TP53
5soft palate cancer10.2TNF, TP53
6pulmonary subvalvular stenosis10.2TNF, TP53
7developmental and speech delay due to sox5 deficiency10.2FAS, TNF
8actinic lichen planus10.2TNF, TP53
9dancing eyes-dancing feet syndrome10.1FAS, TNF
10cryoglobulinemia10.1FAS, TNF
11alcohol abuse10.1FAS, TP53
12liver leiomyosarcoma10.1TNF, TP53
13blepharochalasis10.1TNF, TP53
14single ventricular heart10.1FAS, TNF
15mixed mineral dust pneumoconiosis10.1FAS, TNF
16nasal cavity carcinoma in situ10.0FAS, IL7
17periodic limb movement disorder10.0TNF, TP53
18breast cancer9.9
19obesity9.9
20melanoma9.9
21hypocalciuric hypercalcemia, type i9.9FAS, TNF, TP53
22pupil disease9.9FAS, TNF
23lymphangioleiomyomatosis9.8
24gastric cancer9.8
25leukemia9.8
26morbid obesity9.8
27graves' disease9.8
28ovarian cancer9.8
29cervicitis9.8
30dermatitis9.8
31cerebritis9.8
32kidney disease9.8
33thyroiditis9.8
34peritonitis9.8
35polycystic kidney disease9.8
36aneurysm9.8
37endotheliitis9.8
38villoglandular variant cervical mucinous adenocarcinoma9.8RHOH, TNF
39chronic myelomonocytic leukemia9.8FAS, IL7, TP53
40leukemia, acute myeloid9.7PICALM, TNF, TP53
41optic nerve disease9.7FAS, TNF
42schizophrenia9.7
43colorectal cancer9.7
44lung cancer9.7
45hepatocellular carcinoma9.7
46asthma9.7
47renal cell carcinoma9.7
48attention deficit-hyperactivity disorder9.7
49alzheimer disease9.7
50nail-patella syndrome9.7

Graphical network of the top 20 diseases related to Thyroid Lymphoma:



Diseases related to thyroid lymphoma

Symptoms for Thyroid Lymphoma

About this section

Drugs & Therapeutics for Thyroid Lymphoma

About this section

Drugs for Thyroid Lymphoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 105)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
rituximabapprovedPhase 4, Phase 3, Phase 21582174722-31-710201696
Synonyms:
AntiCD20
IDEC-102
IDEC-C2B8
 
Ig gamma-1 chain C region
MabThera
Mabthera
Rituxan
rituximab
2
MethotrexateapprovedPhase 414441959-05-2, 59-05-2126941
Synonyms:
4-amino-10-methylfolic acid
4-amino-N(10)-Methylpteroylglutamic acid
Abitrexate
Amethopterin
Amethopterine
Antifolan
Arbitrexate
Emtexate
Folex
HDMTX
L-Amethopterin
Ledertrexate
MTX
Metatrexan
Methopterin
Methotextrate
 
Methotrate
Methotrexat
Methotrexate
Methotrexate Sodium
Methotrexatum
Methylaminopterin
Methylaminopterinum
Metoject
Metotrexato
Mexate
Méthotrexate
N-Bismethylpteroylglutamic Acid
N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid
Otrexup
Rasuvo
Rheumatrex
Rheumatrex Dose Pack
Trexall
3
PrednisoloneapprovedPhase 4108250-24-85755
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bio-0666
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
CO-Hydeltra
CPD000718761
Co-Hydeltra
Codelcortone
Cordrol
Cortalone
Cotogesic
Cotolone
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
Delta(1)-dehydrohydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Delta-Ef-Cortelan
Delta-Stab
Delta-stab
Deltacortenol
Deltacortril
Deltacortril Enteric
Deltahydrocortisone
Deltasolone
Deltisilone
Depo-Medrol
Derpo PD
Derpo Pd
Dexa-Cortidelt Hostacortin H
Dexa-Cortidelt hostacortin H
Di Adreson F
Di-Adreson F
Di-Adreson-F
Di-adreson F
DiAdresonF
Dicortol
Donisolone
Dydeltrone
EINECS 200-021-7
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
Flo-pred
HMS1568H10
HMS2090J05
HSDB 3385
Hostacortin H
Hydeltra
Hydeltra-Tba
Hydeltrasol
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
I-Pred
Inflamase Forte
Inflamase Mild
K 1557
Key-Pred
Klismacort
LMST02030179
LS-7669
Lentosone
Lite Pred
M-Predrol
MLS001304083
 
MLS002154250
MLS002207037
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meti-Derm
Meticortelone
Metreton
Millipred
MolPort-002-507-147
NCGC00179649-01
NSC 9120
NSC9120
NSC9900
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
Ocu-Pred
Ocu-Pred Forte
Omnipred
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
PRDL
PRED-G
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Predni-Dome
Prednicen
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone
Prednisolone (JP15/USP/INN)
Prednisolone (anhydrous)
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolone [INN:BAN:JAN]
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Prestwick_404
Rolisone
S1737_Selleck
SAM002264639
SMR000718761
SPBio_002367
Scherisolon
Solone
Steran
Sterane
Sterolone
Supercortisol
UNII-9PHQ9Y1OLM
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
Ultracortene-hydrogen
ZINC03833821
component of Ataraxoid
component of K-Predne-Dome
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
prednisolone
4
MethylprednisoloneapprovedPhase 4108283-43-26741
Synonyms:
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6alpha-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6-Methylprednisolone
6-alpha-Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
A-methapred
AC1L1N7A
Artisone-Wyeth
Artisone-wyeth
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
Besonia
Bio-0658
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
Depo-Medrol (acetate)
Depo-medrol
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
LMST02030178
LS-118498
Lemod
M0639_SIGMA
M1665
MEPRDL
MLS000028541
MLS001148159
MLS002207191
Medesone
Medixon
Medlone 21
 
Medrate
Medrol
Medrol (TN)
Medrol Adt Pak
Medrol Dosepak
Medrol adt pak
Medrol dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
NSC-19987
NSC19987
Nirypan
Noretona
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Prestwick_622
Promacortine
Reactenol
S1733_Selleck
SAM002589984
SMR000058330
SPBio_002377
Sieropresol
Solomet
Solu-medrol
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
methylprednisolone
methylprenisolone
5
Folic Acidapproved, nutraceuticalPhase 4292459-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic Acid
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
 
Folsaeure
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
6ImmunoglobulinsPhase 4, Phase 3, Phase 24477
7Immunologic FactorsPhase 4, Phase 3, Phase 2, Phase 118483
8Immunosuppressive AgentsPhase 4, Phase 2, Phase 110422
9AntibodiesPhase 4, Phase 3, Phase 24477
10Protective AgentsPhase 4, Phase 05651
11AntimetabolitesPhase 4, Phase 2, Phase 3, Phase 19454
12Antirheumatic AgentsPhase 4, Phase 3, Phase 28496
13Antimetabolites, AntineoplasticPhase 4, Phase 2, Phase 15770
14Neuroprotective AgentsPhase 41376
15Prednisolone acetatePhase 41082
16Peripheral Nervous System AgentsPhase 418510
17Prednisolone hemisuccinatePhase 41082
18Vitamin B ComplexPhase 42847
19Folic Acid AntagonistsPhase 41643
20Anti-Inflammatory AgentsPhase 48478
21AntiemeticsPhase 43213
22Prednisolone phosphatePhase 41082
23Methylprednisolone HemisuccinatePhase 41082
24Nucleic Acid Synthesis InhibitorsPhase 43836
25HormonesPhase 411748
26Hormone AntagonistsPhase 410002
27Methylprednisolone acetatePhase 41082
28Gastrointestinal AgentsPhase 46401
29Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 49988
30glucocorticoidsPhase 43896
31Dermatologic AgentsPhase 44555
32Antineoplastic Agents, HormonalPhase 44256
33Vitamin B9NutraceuticalPhase 42924
34Folinic AcidNutraceuticalPhase 42604
35FolateNutraceuticalPhase 42924
36Antiviral AgentsPhase 2, Phase 38071
37Trace ElementsPhase 3, Phase 23900
38DeoxyglucosePhase 2, Phase 397
39RadiopharmaceuticalsPhase 2, Phase 3362
40MicronutrientsPhase 3, Phase 23901
41Fluorodeoxyglucose F18Phase 2, Phase 3356
42Anti-Infective AgentsPhase 3, Phase 2, Phase 117220
43Iodine-131 anti-B1 antibodyPhase 3, Phase 252
44Antibodies, MonoclonalPhase 3, Phase 22413
45Anti-Infective Agents, LocalPhase 3, Phase 2984
46
IodinePhase 3, Phase 2, Phase 04947553-56-2807
Synonyms:
I2
Iode
Iodine-molecule
 
Iodio
Iodum
Jod
Jood
Tincture iodine
47cadexomer iodinePhase 3, Phase 2, Phase 0456
48
DenosumabapprovedPhase 2120615258-40-7
Synonyms:
615258-40-7
AMG-162
D03684
Denosumab
 
Denosumab (USAN)
Denosumab (genetical recombination)
Denosumab (genetical recombination) (JAN)
Prolia
Xgeva
49
Cyclophosphamideapproved, investigationalPhase 2264350-18-0, 6055-19-22907
Synonyms:
(+-)-Cyclophosphamide
(-)-Cyclophosphamide
(RS)-Cyclophosphamide
1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine
1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin
2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide
4-Hydroxy-cyclophosphan-mamophosphatide
50-18-0
60007-95-6
6055-19-2 (monohydrate)
75526-90-8
AC1L1EQQ
AI3-26198
ASTA
ASTA B518
Asta B 518
B 518
B-518
BRN 0011744
BSPBio_002099
Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester
C 0768
C07888
C7H15Cl2N2O2P
CB 4564
CB-4564
CCRIS 188
CHEBI:4027
CHEMBL32520
CHEMBL88
CID2907
CP
CPA
CTX
CY
Ciclofosfamida
Ciclofosfamida [INN-Spanish]
Ciclofosfamide
Ciclophosphamide
Ciclophosphamide [INN]
Clafen
Claphene
Cycloblastin
Cyclophosphamid
Cyclophosphamide
Cyclophosphamide (INN)
Cyclophosphamide (TN)
Cyclophosphamide (anhydrous form)
Cyclophosphamide (anhydrous)
Cyclophosphamide Monohydrate
Cyclophosphamide Sterile
Cyclophosphamide anhydrous
Cyclophosphamide, (+-)-Isomer
Cyclophosphamides
Cyclophosphamidum
Cyclophosphamidum [INN-Latin]
Cyclophosphan
Cyclophosphane
Cyclophosphanum
Cyclophosphoramide
Cyclostin
Cyklofosfamid
Cyklofosfamid [Czech]
Cytophosphan
Cytophosphane
Cytoxan
Cytoxan (TN)
Cytoxan Lyoph
D,L-Cyclophosphamide
D07760
DB00531
 
DivK1c_000246
EINECS 200-015-4
EU-0100238
Endoxan
Endoxan R
Endoxan-Asta
Endoxana
Endoxanal
Endoxane
Enduxan
Genoxal
HMS2090A12
HSDB 3047
Hexadrin
IDI1_000246
KBio1_000246
KBio2_001338
KBio2_003906
KBio2_006474
KBio3_001319
KBioGR_000888
KBioSS_001338
LS-1302
LS-99787
Ledoxina
Lopac-C-0768
Lopac0_000238
Lyophilized Cytoxan
Mitoxan
MolPort-001-783-420
N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide
N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
NCGC00015209-01
NCGC00015209-03
NCGC00015209-06
NCGC00091741-02
NCGC00091741-03
NCI-C04900
NCI60_002097
NINDS_000246
NSC 26271
NSC-26271
NSC26271
NSC273033
NSC273034
Neosar
Occupation, cyclophosphamide exposure
Procytox
RCRA waste no. U058
Rcra Waste Number U058
Rcra waste number U058
Revimmune
S1217_Selleck
SK 20501
SPBio_001071
STK177249
STOCK2S-91217
Semdoxan
Sendoxan
Senduxan
Spectrum2_001146
Spectrum3_000370
Spectrum4_000304
Spectrum5_000795
Spectrum_000858
UNII-6UXW23996M
WLN: T6MPOTJ BO BN2G2G
Zyklophosphamid
Zyklophosphamid [German]
bis(2-Chloroethyl)phosphami de cyclic propanolamide
bis(2-Chloroethyl)phosphamide cyclic propanolamide ester
cyclophosphamide
50
Vincristineapproved, investigationalPhase 28632068-78-2, 57-22-75978
Synonyms:
22-Oxovincaleukoblastin
22-Oxovincaleukoblastine
28379-27-3
57-22-7
AC1L1LJC
C07204
C46H56N4O10
CCRIS 5763
CHEBI:28445
CID5978
D08679
DB00541
EINECS 200-318-1
HMS2090E19
HSDB 3199
Indole alkaloid
LCR
LS-228
Leurocristine
Lilly 37231 (1:1 sulfate salt)
Liposomal Vincristine
Marqibo
NCGC00163700-01
NCI-C04864
NCI60_026703
NSC-67574
Onco TCS
 
Oncovin
Oncovin (1:1 sulfate salt)
Oncovine
Tecnocris
Tecnocris (TN)
UNII-5J49Q6B70F
VCR
VIN
Vincaleukoblastine, 22-oxo- 22-Oxovincaleukoblastine
Vincasar
Vincasar (1:1 sulfate salt)
Vincasar PFS
Vincrex
Vincrex (1:1 sulfate salt)
Vincristin
Vincristina
Vincristina [DCIT]
Vincristine (INN)
Vincristine Sulfate
Vincristine Sulfate PFS
Vincristine [INN:BAN]
Vincristinum
Vincristinum [INN-Latin]
Vincrstine
Vincrystine
Vinkristin
Z-D-Val-Lys(Z)-OH
vincristine

Interventional clinical trials:

(show all 37)
idNameStatusNCT IDPhase
1Rituximab (RTX) Therapy in Patients With Active TAORecruitingNCT02378298Phase 4
2Comparison Of Rituximab Versus Tositumomab and Iodine I 131 Tositumomab (BEXXAR® Therapeutic Regimen) For Patients With Relapsed Follicular Non-Hodgkins LymphomaCompletedNCT00268983Phase 3
3Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected CancerCompletedNCT00123760Phase 2, Phase 3
4Expanded Access Study Of BEXXAR® For Low Grade And Transformed Low-Grade Non-Hodgkin's LymphomaCompletedNCT00268203Phase 2
5Retreatment of Patients With Non-Hodgkin's Lymphoma Who Have Previously Responded to Iodine-131 Anti B1 AntibodyCompletedNCT00938041Phase 2
6Iodine-131 Anti-B1 Antibody (Tositumomab and Iodine I 131 Tositumomab) for Previously Untreated, Advanced-stage, Low Grade Non-Hodgkin's LymphomaCompletedNCT00996996Phase 2
7Study of Safety and Efficacy of a Sequential Regimen Consisting of Three Cycles of Fludarabine Followed by Tositumomab and Iodine I 131 TositumomabCompletedNCT00933335Phase 2
8Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum CalciumCompletedNCT00896454Phase 2
9Study of Iodine 131 Anti B1 Antibody for 1st or 2nd Relapsed Indolent B-Cell Lymphomas or B-Cell Lymphomas That Have Transformed to a More Aggressive HistologyCompletedNCT00950755Phase 2
10A Randomized Study of Iodine-131 Anti-b1 Antibody Versus Anti-b1 Antibody in Chemotherapy-relapsed/Refractory Low-grade or Transformed Low-grade Non-Hodgkin's Lymphoma (NHL)CompletedNCT01573000Phase 2
11Iodine-131 Anti-B1 Antibody Consolidation for Patients With Non-Hodgkin's Lymphoma Following First-line CHOPCompletedNCT01868035Phase 2
12Study of Iodine-131 Anti-B1 Antibody for Patients With Non Hodgkin's Lymphoma Who Have Previously Received RituximabCompletedNCT00996593Phase 2
13Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell LymphomaCompletedNCT00992992Phase 2
14A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H...CompletedNCT00923481Phase 2
15Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell TransplantCompletedNCT00321932Phase 2
16Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK1/2/3, ROS1, or ALK Gene Rearrangements (Fusions)RecruitingNCT02568267Phase 2
17External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain MetastasesRecruitingNCT00637637Phase 2
18A Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade ), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Cancer (MTC)Active, not recruitingNCT00923247Phase 1, Phase 2
19Study of Oral PXD101 in Patients With Advanced Solid Tumors or LymphomaCompletedNCT00413075Phase 1
20Spectroscopy With Surface Coils and DecouplingCompletedNCT00581815Phase 1
21Study of XL184 (Cabozantinib) in Adults With Advanced MalignanciesCompletedNCT00215605Phase 1
22Depsipeptide to Treat Thyroid and Other Advanced CancersCompletedNCT00048334Phase 1
23Rapamycin With Grapefruit Juice for Advanced MalignanciesCompletedNCT00375245Phase 1
24Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver DysfunctionRecruitingNCT01638533Phase 1
25CC-486 (Oral Azacitidine) Bioequivalence Study in Patients With Solid Tumor or Hematologic MalignanciesRecruitingNCT02223052Phase 1
26TAA-Specific CTLS for Solid Tumors (TACTASOM)RecruitingNCT02239861Phase 1
27Association Between Hepatitis C Virus Infection and Hematologic and Thyroid CancersCompletedNCT00342641
28B-Receptor Signaling in CardiomyopathyCompletedNCT01135849
29A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoid and Peroxisome-proliferator-activated Receptor (PPARy) ExpressionCompletedNCT00718770Phase 0
30Vegetable Garden Feasibility Trial to Promote Function in Older Cancer SurvivorsCompletedNCT02150148
3111C-Acetate PET/CT Non-FDG-Avid TumorsRecruitingNCT00687778
32Non-Invasive Cerenkov Luminescence Imaging of Lymphoma, Leukemia and Metastatic Lymph NodesRecruitingNCT01664936
3310 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used PimecrolimusRecruitingNCT00568997
34PET Imaging of Patients With Cancer Using 124I-PU-ADRecruitingNCT02751554
35The Effect of Human Placental Explants and Pregnant Women Sera on Cancer CellsRecruitingNCT01879436
36Evaluation of Adverse Long-term Effects in Young Adult Survivors of Acute LeukemiaRecruitingNCT02345915Phase 0
37Cardiometabolic Status in Childhood Acute Lymphoblastic LeukemiaWithdrawnNCT01688752

Search NIH Clinical Center for Thyroid Lymphoma

Genetic Tests for Thyroid Lymphoma

About this section

Anatomical Context for Thyroid Lymphoma

About this section

MalaCards organs/tissues related to Thyroid Lymphoma:

33
Thyroid, B cells, Bone, Brain, Breast, Lung, Liver

Animal Models for Thyroid Lymphoma or affiliated genes

About this section

MGI Mouse Phenotypes related to Thyroid Lymphoma:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00011869.4FAS, PICALM, TP53
2MP:00053718.7CHST14, FAS, TNF, TP53
3MP:00053828.5CHST14, FAS, TNF, TP53
4MP:00053708.3CHST14, FAS, PICALM, TNF, TP53
5MP:00107718.3CHST14, FAS, PICALM, TNF, TP53
6MP:00053798.1FAS, IL7, RHOH, TNF, TP53
7MP:00053847.3CHST14, FAS, PICALM, RHOH, TNF, TP53
8MP:00053977.3FAS, IL7, PICALM, RHOH, TNF, TP53
9MP:00053877.0FAS, IL7, PICALM, RHOH, TNF, TP53

Publications for Thyroid Lymphoma

About this section

Articles related to Thyroid Lymphoma:

(show top 50)    (show all 169)
idTitleAuthorsYear
1
The Mechanism of Interferon Refractoriness During Hepatitis C Virus Infection and Its Reversal with a Peroxisome Proliferator-Activated Receptor I+ Agonist. (25734487)
2015
2
Transient Cardiomyopathy and Quadriplegia Induced by Ephedrine Decongestant. (26664316)
2015
3
Thioimidazoline based compounds reverse glucocorticoid resistance in human acute lymphoblastic leukemia xenografts. (25967739)
2015
4
Tetra-phocomelia: the seal limb deformity - a case report. (25859493)
2015
5
The effects of periodontal therapy on gingival crevicular fluid matrix metalloproteinase-8, interleukin-6 and prostaglandin E2 levels in patients with rheumatoid arthritis. (26575440)
2015
6
Treating peritoneal mesothelioma with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. A case series and review of the literature. (26382910)
2015
7
Association between I^2-Adrenergic Receptor-16Arg/Gly Gene Polymorphism and Chronic Obstructive Pulmonary Disease Risk:Systematic Review and Meta-Analysis. (25909056)
2014
8
Delineation of key XRCC4/Ligase IV interfaces for targeted disruption of non-homologous end joining DNA repair. (23794378)
2014
9
Effect of HIV infection on pregnancy-related mortality in sub-Saharan Africa: secondary analyses of pooled community-based data from the network for Analysing Longitudinal Population-based HIV/AIDS data on Africa (ALPHA). (23683643)
2013
10
Standardized serum GM-CSF autoantibody testing for the routine clinical diagnosis of autoimmune pulmonary alveolar proteinosis. (24275678)
2013
11
Helicobacter pylori heterogeneity in patients with gastritis and peptic ulcer disease. (23523597)
2013
12
3A T DCE-MRI assessment of synovitis of the interphalangeal joints in patients with erosive osteoarthritis for treatment response monitoring. (22669732)
2013
13
The effect of mass immunisation campaigns and new oral poliovirus vaccines on the incidence of poliomyelitis in Pakistan and Afghanistan, 2001-11: a retrospective analysis. (22766207)
2012
14
Cyclin D1 polymorphism in non-small cell lung cancer in a Portuguese population. (23396251)
2012
15
PAX3-FKHR regulates the expression of pleiotrophin to mediate motility in alveolar rhabdomyosarcoma cells. (24348888)
2012
16
Walker-Warburg syndrome. (22691590)
2011
17
Nitric oxide synthase 2 gene polymorphisms are associated with prostatic volume in Korean men with benign prostatic hyperplasia. (20562898)
2010
18
Intestinal perforation in a patient with continuous ambulatory peritoneal dialysis. (19054773)
2009
19
Pain relief after cervical ganglionectomy (C2 and C3) for the treatment of medically intractable occipital neuralgia. (18216457)
2008
20
Late-infantile neuronal ceroid lipofuscinosis (CLN2/Jansky-Bielschowsky type) in Oman. (17690061)
2007
21
Benefits of gene transduction of granulocyte macrophage colony-stimulating factor in cancer vaccine using genetically modified dendritic cells. (17786327)
2007
22
Arsenic exposure is associated with decreased DNA repair in vitro and in individuals exposed to drinking water arsenic. (16882524)
2006
23
Interleukin-1 receptor antagonist is upregulated during diet-induced obesity and regulates insulin sensitivity in rodents. (16385385)
2006
24
Noninvasive prenatal diagnosis for hemoglobin Bart's hydrops fetalis. (16158819)
2005
25
A modified Trastuzumab antibody for the immunohistochemical detection of HER-2 overexpression in breast cancer. (15812476)
2005
26
Expression profiling of sodium butyrate (NaB)-treated cells: identification of regulation of genes related to cytokine signaling and cancer metastasis by NaB. (15318170)
2004
27
Nicotinic acetylcholine receptor alpha 7 regulates cAMP signal within lipid rafts. (12748066)
2003
28
Direct measurement of glucose gradients and mass transport within islets of Langerhans. (12711325)
2003
29
Cathepsin D polymorphism in Italian elderly subjects with sporadic late-onset Alzheimer's disease. (12826741)
2003
30
Polyclonal and allergen-induced cytokine responses in children with elevated immunoglobulin E but no atopic disease. (12569974)
2002
31
Acquired immunodeficiency syndrome in older African Americans. (11991333)
2002
32
Neonatal pulmonary arteriovenous malformation in hereditary haemorrhagic telangiectasia. (12391000)
2002
33
Tumor cell expression of CD59 is associated with resistance to CD20 serotherapy in patients with B-cell malignancies. (11394505)
2001
34
Plasma brain natriuretic peptide as a parameter to assess efficacy of continuous intravenous infusion of prostacyclin (epoprostenol) to treat severe primary pulmonary hypertension: a case report. (11289503)
2000
35
Acute myocardial infarction in patients with angiographically normal coronary arteries: clinical features and medium term follow-up]. (10663915)
2000
36
Leber's hereditary optic neuropathy: clinical and molecular genetic findings in a patient with a new mutation in the ND6 gene. (10447650)
1999
37
The bactericidal/permeability-increasing protein (BPI) is present in specific granules of human eosinophils. (9616176)
1998
38
House-dust mite hypersensitivity, eczema, and other nonpulmonary manifestations of allergy. (10096817)
1998
39
A leucine-to-phenylalanine substitution in the acetylcholine receptor ion channel in a family with the slow-channel syndrome. (7538206)
1995
40
A reconstituted, apolipoprotein A-I containing lipoprotein reduces tumor necrosis factor release and attenuates shock in endotoxemic rabbits. (8324886)
1993
41
Pharmacologic treatment of colonic pseudo-obstruction. (8348871)
1993
42
An integrated view of the role of the endocrine system in the genesis of the osteoporosis associated with aging. (8461573)
1993
43
Effect of extracorporeal shockwave lithotripsy for urolithiasis on concentrations of creatine kinase isozymes in patient serum and urine. (1413305)
1992
44
Significance of the concentrated red cell and albumin priming method with particular reference to anaphylatoxin generation. (1728718)
1992
45
An unusual presentation of pulmonary alveolar microlithiasis and diaphyseal aclasia. (1540813)
1992
46
Relationship between proteolytic enzymes and atherosclerosis in aortic aneurysms. (1851335)
1991
47
Congenital epulis: a case report. (3293655)
1988
48
A granular-cell pituicytoma of the neurohypophysis. (521870)
1979
49
Fibro-adenoma of the ovary with ascites and hydrothorax (Meigs' syndrome). (14814476)
1951
50

Variations for Thyroid Lymphoma

About this section

Expression for genes affiliated with Thyroid Lymphoma

About this section
Search GEO for disease gene expression data for Thyroid Lymphoma.

Pathways for genes affiliated with Thyroid Lymphoma

About this section

Pathways related to Thyroid Lymphoma according to GeneCards Suite gene sharing:

(show all 13)
idSuper pathwaysScoreTop Affiliating Genes
1
Show member pathways
9.6FAS, TP53
29.4FAS, TNF
3
Show member pathways
9.4FAS, TNF
4
Show member pathways
9.0FAS, TNF, TP53
5
Show member pathways
9.0FAS, TNF, TP53
6
Show member pathways
9.0FAS, TNF, TP53
79.0FAS, TNF, TP53
8
Show member pathways
9.0FAS, TNF, TP53
9
Show member pathways
9.0FAS, TNF, TP53
109.0FAS, TNF, TP53
119.0FAS, TNF, TP53
129.0FAS, TNF, TP53
13
Show member pathways
7.8FAS, IL7, RHOH, TNF, TP53

GO Terms for genes affiliated with Thyroid Lymphoma

About this section

Biological processes related to Thyroid Lymphoma according to GeneCards Suite gene sharing:

(show all 13)
idNameGO IDScoreTop Affiliating Genes
1necroptotic signaling pathwayGO:009752710.0FAS, TNF
2negative regulation of extrinsic apoptotic signaling pathway in absence of ligandGO:200124010.0IL7, TNF
3cellular response to organic cyclic compoundGO:00714079.9FAS, TNF
4response to glucocorticoidGO:00513849.8FAS, TNF
5organ morphogenesisGO:00098879.8IL7, TNF
6extrinsic apoptotic signaling pathwayGO:00971919.7FAS, TNF
7positive regulation of apoptotic processGO:00430659.6FAS, TNF
8extrinsic apoptotic signaling pathway via death domain receptorsGO:00086259.6FAS, TNF
9negative regulation of apoptotic processGO:00430669.3FAS, IL7, TP53
10activation of cysteine-type endopeptidase activity involved in apoptotic processGO:00069199.3FAS, TNF
11protein complex assemblyGO:00064619.1FAS, PICALM, TP53
12transformed cell apoptotic processGO:00069279.1FAS, TNF
13immune responseGO:00069559.0FAS, IL7, TNF

Sources for Thyroid Lymphoma

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet